Chromadex and the nih-niaid rocky mountain laboratories announce study to assess the therapeutic potential of niagen® in covid-19 animal models

Chromadex corp. (nasdaq:cdxc) announced today the initiation of a preclinical study in collaboration with the national institute of allergy and infect

CZR Ratings Summary

CZR Quant Ranking